RBC Capital boosted their target price on shares of First Solar (NASDAQ:FSLR) from $47.00 to $48.00 in a research note issued on Thursday, American Banking & Market News reports. RBC Capital’s price objective indicates a potential downside of 30.84% from the stock’s previous close. First Solar, Inc. (NASDAQ:FSLR) shares after opening at $57.10 moved to $70.99 on last trade day and at the end of the day closed at $69.40. Company price to sales ratio in past twelve months was calculated as 2.09 and price to cash ratio as 3.91. First Solar, Inc. (NASDAQ:FSLR) showed a positive weekly performance of 29.24 %.
Sears Holdings Corporation (NASDAQ:SHLD) announced that its board of directors approved the separation of its Lands’ End business by means of a pro-rata spin-off transaction. Sears Holdings Corp (NASDAQ:SHLD) shares advanced 5.27% in last trading session and ended the day on $48.30. SHLD return on equity ratio is recorded as -61.10% and its return on assets is -7.10%. Sears Holdings Corp (NASDAQ:SHLD) yearly performance is -6.67%.
Centrais Eletricas Brasileiras SA (ADR) (NYSE:EBR.B) said its Board of Directors homologated on Jan. 31 entrance of its subsidiary, Furnas Centrais Eletricas SA Furnas (Furnas), into a special purpose vehicle (SPV) Energia Olimpica SA.Says the objective of Energia Olimpica SA is the possibility of installation and construction of the Vila Olimpica substation 138/13.8 kV-3×40 MVA and two underground transmission lines of 138 kV. Centrais Eletricas Brasileiras SA (ADR) (NYSE:EBR.B) shares moved up 2.48% in last trading session and was closed at $4.13 while trading in range of $4.05 – $4.22 – Centrais Eletricas Brasileiras SA (ADR) (NYSE:EBR.B) year to date (YTD) performance is -8.49%.
BlueMountain Capital Management, LLC announced that one of the United States’ leading independent proxy voting advisory firms, Institutional Shareholder Services (“ISS”), recommends that shareholders of Taro Pharmaceutical Industries Ltd. (NYSE:TARO) vote FOR the BlueMountain nominees in Items 6.1 and 6.2 (and AGAINST the company’s nominees in Items 5.1 and 5.2) at the company’s March 27, 2014 extraordinary general meeting. Taro Pharmaceutical Industries Ltd. (NYSE:TARO) weekly performance is 9.34%. On last trading day company shares ended up $121.32. Taro Pharmaceutical Industries Ltd. (NYSE:TARO) distance from 50-day simple moving average (SMA50) is 12.18%. Analysts mean target price for the company is $85.00.